Determining the reporting quality of RCTs in clinical pharmacology

British Journal of Clinical Pharmacology

Volumn 58, Issue 1, 2004, Pages 61-65

  Mills, Edward ^a,f,g   Loke, Yoon K ^a   Wu, Ping ^b   Montori, Victor M ^c,f   Perri, Daniel ^d   Moher, David ^e   Guyatt, Gordon ^f  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Mayo Clinic   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

Clinical pharmacology; Methodology; Randomized controlled trials; Reporting quality

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; DATA ANALYSIS; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

HUMANS; OBSERVER VARIATION; PERIODICALS; PHARMACOLOGY; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 3142559736     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.2092.x     Document Type: Article

References (20)

1. Moher D, Schulz KF, Altman DG. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-4.
2. Egger M, Juni P, Bartlett C. Value of flow diagrams in reports of randomized controlled trials. JAMA 2001; 285: 1996-9.
3. Huwiler-Muntener K, Juni P, Junker C, Egger M. Quality of reporting of randomized trials as a measure of methodologic quality. JAMA 2002; 287: 2801-4.
4. Nuovo J, Melnikow J, Chang D. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. JAMA 2002; 287: 2813-4.
5. Bhandari M, Guyatt GH, Lochner H, Sprague S, Tornetta P 3rd. Application of the Consolidated Standards of Reporting Trials (CONSORT) in the Fracture Care Literature. J Bone Joint Surg Am 2002; 84-A: 485-9.
6. Devereaux PJ, Manns BJ, Ghali WA, Quan H, Guyatt GH. The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials 2002; 23: 380-8.
7. Clarke M, Alderson P, Chalmers I. Discussion sections in reports of controlled trials published in general medical journals. JAMA 2002; 287: 2799-801.
8. Clarke M, Chalmers I. Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? JAMA 1998; 280: 280-2.
9. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273: 408-12.
10. Schulz KF. Subverting randomization in controlled trials. JAMA 1995; 274: 1456-8.
11. Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH. In the dark: the reporting of blinding status in randomized controlled trials. J Clin Epidemiol 2002; 55: 787-90.
12. Schindel L. The placebo dilemma. Eur J Clin Pharmacol 1978; 13: 231-5.
13. Yank V, Rennie D. Reporting of informed consent and ethics committee approval in clinical trials. JAMA 2002; 287: 2835-8.
14. Montori VM, Guyatt GH. Intention-to-treat principle. CMAJ 2001; 165: 1339-41.
15. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001; 285: 437-43.
16. Loke YK, Derry S. Reporting of adverse drug reactions in randomised controlled trials - a systematic survey. BMC Clin Pharmacol 2001; 1: 3.
17. Lexchin J, Bero L, Djulbegovic B. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. Br Med J 2003; 326: 1167-70.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
19. Soares HP, Daniels S, Kumar A et al. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. Br Med J 2004; 328: 22-4.
20. Bossuyt EM, Reitsma JB, Bruns DE, et al. Standards for Reporting of Diagnostic Accuracy. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003; 138: W1-12.